Apart from bringing our own innovative Precision Oncology candidates to the market, we are always happy to discuss potential partnering opportunities.
We are always seeking innovative drug discovery partnerships, ideally fusing your target know-how with our leading radioisotope platform technologies to develop next generation diagnostic and therapeutic agents that will help fight serious and difficult to treat cancer diseases.
